News

SWOG Expands Cancer Clinical Trial Access for U.S. Military Veterans

Nov. 3, 2016 FOR IMMEDIATE RELEASE    SWOG Expands Cancer Clinical Trial Access for U.S. Military Veterans PORTLAND, OR – For the second year, SWOG, the cancer clinical trials network, and its charity, The Hope Foundation, are providing $125,000 to five U.S. Department of Veterans Affairs medical centers to expand access to cancer clinical trials. …

60th Anniversary Fundraising Challenge

You Give $100,000. Young Investigator Programs Get $200,000. Join our matching gift campaign.  2016 Goal $100,000 (82% Reached) [wppb progress=82 option=red fullwidth=true] As SWOG turns 60, more than 200,000 trial participants have been enrolled. Let’s raise $200,000 in their honor. When SWOG members give a total of $100,000 in 2016, The Hope Foundation will double …

Fall 2016 Group Meeting Recap

60 Never Looked So Good! Over 800 SWOG members, industry professionals, corporate representatives, and cancer research advocates gathered for the fall 2016 group meeting at the Hyatt Regency in Chicago Sept. 14-17. Throughout four days, 30 disease, research, and administrative committees met to review progress, identify needs, and plan future research directions. “Over the course of our 60-year …

6 Young Investigators Named for 2016 Training Course

The 2016 participants for SWOG‘s Young Investigator Training Course (YITC) to be held in Seattle from Sept. 26-28 were reviewed and selected in late August. The YITC is SWOG’s premier education opportunity for early career investigators, and remains a major way that new trials and new leaders get into SWOG’s network.  This year’s cohort includes: Uma M. …

Two 2016 Coltman Fellows, Three Impact Awards Announced

2016 Coltman Fellows Melissa Accordino, MD, of Columbia University Medical Center, and Anne Chiang, MD, PhD, of the Yale University School of Medicine have been awarded Coltman Fellowships from The Hope Foundation. Accordino’s fellowship will support her work comparing disease monitoring in patients with metastatic breast and colorectal cancers. Chiang will utilize Hope support for her efforts …

#SWOGonc Highlights from the Spring of SWOG’s 60th Year

Once again, we closed out April in sunny San Francisco participating in the Spring 2016 SWOG Group Meeting. The Twitter highlights below, collected from the #SWOGonc and #SWOGturns60 hashtags, provide a brief introduction to a few of the engaging events and conversations held throughout the week. After six decades, SWOG is reflecting on 1,300 clinical trials and honoring …

Reflecting on Our Past, Investing in Our Future

SWOG Chair Dr. Charles Blanke previews the SWOG spring 2016 meeting and 60th anniversary. Originally published on the SWOG Front Line April 1, 2016 – When we gather together in San Francisco at the end of this new month, we will kick off our 60th anniversary celebration. Big milestones invite reflection – on what we’ve done and …

A Look at SWOG’s Impact

Because answers to cancers come from clinical trials Since 1956, more than 200,000 participants have enrolled in SWOG-led studies; the resulting advancements in treatment and prevention have improved the lives of millions more. Why Cancer Clinical Trials? from The Hope Foundation on Vimeo. More about the group: SWOG has roughly 5,000 affiliated physician researchers – along …

Exhibit at 2016 Meetings in SWOG’s 60th Year!

Help us honor six decades of collaborative cancer research SWOG is a worldwide network of researchers that design and conduct cancer clinical trials. The Group’s goal is to change medical practice so it improves the lives of people with cancer. Since 1978, SWOG has held Group Meetings twice yearly to review progress, conduct Group business, and …

News from SWOG: Triple Drug Combination Beats Standard Treatment in Myeloma Trial

A SWOG trial shows bortezomib, lenalidomide, and dexamethasone delays recurrence and lengthens life for myeloma patients, indicating a possible new standard of care. [cta]View the Press Release[/cta] SWOG is a publicly funded worldwide network of researchers who design and conduct cancer clinical trials. The Group’s goal is to change medical practice so it improves the …

Michael LeBlanc, PhD
Group Statistician

Updates, Right To Your Inbox

JOIN OUR EMAIL LIST

Johanna Horn, President & CEO

Give to a cause with proven resultsHope Works For Us All